Navigation Links
Asymchem Announces Fall Process Symposium Confirmed List of Speakers

TEDA TIANJIN, China, Sept. 4 /PRNewswire/ -- Asymchem Life Science (Tianjin) Co. Ltd., a wholly-owned subsidiary of Asymchem Laboratories Inc., a leading research-based contract manufacturer of API's and intermediates and Drug Products to the pharmaceutical industry, is pleased to issue the final confirmed list of speakers for the upcoming Fall Symposium in Process Chemistry held in Asymchem Life Science in TEDA Tianjin, P.R. China, from October 17-19, 2009.

Company and Academic speakers to present at Asymchem's Fall Process Chemistry Symposium Oct 17-19, 2009:

     No.  Company     Speaker         Title         Topic
     ---  -------     -------         -----         -----
     1    Merck       Joe Armstong    Senior Dir.,  Innovation as the
                                      Process       Driver of Green
                                      Research      Chemistry Advances in
                                                    the Pharmaceutical

     2    Lilly       Hannah Yu       Scientist     Development of an
                                                    Reaction for the
                                                    Synthesis of a
                                                    Exocyclic Alkene

     3    Pfizer      Yousef          Principal     Evolution of the
                      Hajikarimian    Scientist     manufacturing process
                                                    to UK-369,003-26 / a
                                                    PDE5 inhibitor for
                                                    treatment of multiple

     4    Pfizer      Matt Birchmeier Physical      Crystallization:
                                      properties    Theory, Methods, and
                                      Scientist     Analyses

     5    Concert     Andy Jones      Senior Dir.,  The Challenge of
                                      Chemistry     Large-scale
                                                    Manufacture of
                                                    Deuterated APIs

     6    Lexicon     Winston Wu      Senior Dir.,  Process Chemistry in a
                                      Chemical      Small Biotech Company:
                                      Development   A Case Study

     7    BMS         Mauricio Futran VP, Process   API and Intermediates
                                      R&D           Outsourcing: The
                                                    Changing Value
                                                    Proposition for

     8    BMS         Stephen         VP,           Pharmaceutical Analysis
                      Scypinski       Analytical    in the 21st Century:
                                      R&D           New Challenges and New

     9    Lilly       Scott Bradley   Scientist     NMR-based Reaction
                                                    Monitoring: From Small
                                                    Molecules to Biologics

     10   Roche       Yi Ren          Head of Drug  Process Research of a
                                      Supply and    Glucose Kinase
                                      Discovery     Activator for the
                                      Technology    Treatment of Type-II

     11   University  Richard Hsung   Professor     Total Synthesis of
          of                                        Phomactin A.

     12   University  Andy Evans      Professor     New Asymmetric Methods
          of                                        for Heterocyclic
          Liverpool                                 Synthesis - Total
                                                    Synthesis of
                                                    Marinomycin A

     13   North       Muk Sibi        Professor     Chiral Lewis and
          Dakota                                    Bronsted Acid
          State                                     Catalysis:
          University                                Exploration of

     14   Swiss       Erick Carreira  Professor     Surprises and
          Federal                                   Discoveries with
          Institute                                 Natural Products

     15   West        George          Asst          De Novo Synthesis in
          Virginia    O'Doherty       Professor     Carbohydrate Chemistry

     16   AstraZeneca Andy Wells

     17   Beijing     Xi Zhenfeng     Professor

     18   Nankai      Zhou Qilin      Professor

     19   Tianjin     Sun Yan         Professor

     20   Lanzhou     Wang Rui        Professor

"We are pleased to bring together industrial and academic experts in the field of process chemistry and synthetic organic chemistry for a 3-day event," says Dr. Hao Hong, President and CEO of Asymchem. "The symposium will showcase new developments in the process field and provide a forum of discussion as to the state of the API contract R&D and manufacturing business in China, with a direct view into one of the key suppliers at the forefront."

Asymchem Laboratories is a leading research-based contract manufacturer specialized in the development and compliant manufacturing (Contract Research and Manufacturing Services) of API's and Drug Products serving the pharmaceutical industry. With a 14yr track record, Asymchem is committed to the highest level of quality and excellence in the integrated CMC services arena. For further information, please visit the Asymchem website at

SOURCE Asymchem Life Science (Tianjin) Co. Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Asymchem Announces sFDA Certification for Drug Product Manufacturing
2. Asymchem Continues to Maintain a Good Running Posture, Despite Economic Crisis
3. Asymchem Announces Opening of High Potency API and Drug Product Facility
4. Neusoft Announces New Releases of Flagship Medical Products
5. Hill-Rom Announces Fourth Quarter 2009 Dividend
6. Health2 Resources Announces News Portal, E-News Brief Focused on Patient Centered Medical Home
7. MDS Announces Special Meeting of Shareholders and Record Date
8. N.C. Governor Perdue Announces Application for $28.1 Million in Broadband Recovery Funding
9. Embla(R) Systems Announces the Acquisition of the Sandman(R) Sleep Diagnostic Business from Covidien(R) - Creating the Worlds Largest Sleep Diagnostic Company
10. Saddle Ranch Productions Announces New Releases
11. Selective Insurance Group Announces Officer Appointments
Post Your Comments:
(Date:11/30/2015)... DC (PRWEB) , ... November ... ... Inc. (AIS) is pleased to announce the speakers for “Value-Based Payer-Provider Partnerships: ... lessons learned from three innovative value-based care arrangements: Essentia Health and UCare, ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... around Novus’ TIGR® Matrix Surgical Mesh technology for soft tissue repair in the ... Matrix is a long-term resorbable surgical mesh intended to support and reinforce soft ...
(Date:11/30/2015)... Puerto Rico (PRWEB) , ... November 30, 2015 , ... ... active part of the San Juan Beauty Show held on November 8th and 9th ... was attended by media personalities, hair artists, renowned beauticians and top of the line ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... are pleased to announce their strategic partnership at the Radiological Society of ... Service, Inc., and Winscribe, global providers of cutting-edge dictation and speech-enabled documentation ...
(Date:11/30/2015)... ... 30, 2015 , ... World Patent Marketing , a ... household invention that provides an economical and easy way of gaining customized curtains. ... at 2.6%," says Scott Cooper, CEO and Creative Director of World Patent Marketing. ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Nov. 30, 2015   VolitionRx Limited (NYSE MKT: ... tests for a broad range of cancer types and other ... Micro Conference, which will be held December 1 - 3 in ... VolitionRx will be David Kratochvil , Chief Financial Officer ... Investor Relations. ® blood-based tests for colorectal ...
(Date:11/30/2015)... , November 30, 2015 PFE ... at up to 10 G protein-coupled receptor (GPCR) targets ... to research and develop potential new medicines directed at ... multiple therapeutic areas. --> Heptares Therapeutics ("Heptares"), ... and wholly-owned subsidiary of Sosei Group Corporation ("Sosei"; TSE ...
(Date:11/30/2015)... and REHOVOT, Israel , ... specialty pharmaceutical company focused on acquiring and developing innovative ... announced the appointment of Keith A. Katkin ... Gregory J. Flesher , chief executive officer for ... building successful organizations.  As chairman, he will be able ...
Breaking Medicine Technology: